Penumbra Inc (Penumbra) is a medical device company that designs, develops, and manufactures products for neuro and vascular markets. Its products find use in procedures such as thrombectomy and embolization for treating conditions such as acute ischemic stroke, brain aneurysm, acute limb ischemia, deep vein thrombosis, neuro arteriovenous malformation, body aneurysm among others. Its major products include neurovascular access systems, revascularization devices, embolization coiling systems and microcatheters. The company sells its products to specialist physicians, hospitals and clinics through a direct sales organization. It also distributes its products through distributors globally. It has operations in the US, Brazil, Germany, Australia, Canada, Singapore, France and the UK. Penumbra is headquartered in Alameda, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Penumbra Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Penumbra Inc Company Overview
- Penumbra Inc Company Snapshot
- Penumbra Inc Pipeline Products and Ongoing Clinical Trials Overview
- Penumbra Inc - Pipeline Analysis Overview
- Business Description
- Penumbra Inc - Key Facts
- Penumbra Inc - Major Products and Services
- Penumbra Inc Pipeline Products by Development Stage
- Penumbra Inc Ongoing Clinical Trials by Trial Status
- Penumbra Inc Pipeline Products Overview
- Clinical Decision-Making Tool - Pulmonary Embolism
- Clinical Decision-Making Tool - Pulmonary Embolism Product Overview
- Indigo Aspiration System - Lightning Aspiration Tubing
- Indigo Aspiration System - Lightning Aspiration Tubing Product Overview
- Indigo Aspiration System - Lightning Aspiration Tubing Clinical Trial
- Indigo Aspiration System - Separator 12
- Indigo Aspiration System - Separator 12 Product Overview
- Indigo Aspiration System - Separator 12 Clinical Trial
- Indigo System Aspiration Lightning 7
- Indigo System Aspiration Lightning 7 Product Overview
- Lightning Bolt 7
- Lightning Bolt 7 Product Overview
- Thunderbolt
- Thunderbolt Product Overview
- Thunderbolt Clinical Trial
- Penumbra Inc - Key Competitors
- Penumbra Inc - Key Employees
- Penumbra Inc - Key Employee Biographies
- Penumbra Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Penumbra Inc, Recent Developments
- Jul 02, 2024: Penumbra Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024
- Jun 25, 2024: Penumbra Receives 510(K) Clearance For Indigo Lightning Flash Aspiration System - Select + Catheter
- Apr 24, 2024: Penumbra secures FDA clearance for Lightning Flash 2.0 thrombectomy system
- Feb 14, 2024: Penumbra Obtains Additional 510(K) Clearance For Indigo Aspiration System - Lightning Flash
- Nov 29, 2023: Penumbra enrols first patient in trial of Lightning Flash
- Nov 01, 2023: New Late Breaking Data Demonstrate Penumbra’s Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Improved Patient Outcomes
- Jun 02, 2023: Penumbra introduces new Lightning Bolt7 arterial thrombectomy system
- Apr 04, 2023: Penumbra and Veterans Health Administration to Expand Access to Rehabilitative Care using Virtual Reality
- Feb 22, 2023: Penumbra receives an additional 510(k) clearance for Indigo Aspiration System - Lightning Aspiration Tubing
- Jan 11, 2023: Penumbra announces new thrombectomy system for blood clot removal
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Penumbra Inc Pipeline Products and Ongoing Clinical Trials Overview
- Penumbra Inc Pipeline Products by Equipment Type
- Penumbra Inc Pipeline Products by Indication
- Penumbra Inc Ongoing Clinical Trials by Trial Status
- Penumbra Inc, Key Facts
- Penumbra Inc, Major Products and Services
- Penumbra Inc Number of Pipeline Products by Development Stage
- Penumbra Inc Pipeline Products Summary by Development Stage
- Penumbra Inc Ongoing Clinical Trials by Trial Status
- Penumbra Inc Ongoing Clinical Trials Summary
- Clinical Decision-Making Tool - Pulmonary Embolism - Product Status
- Clinical Decision-Making Tool - Pulmonary Embolism - Product Description
- Indigo Aspiration System - Lightning Aspiration Tubing - Product Status
- Indigo Aspiration System - Lightning Aspiration Tubing - Product Description
- Indigo Aspiration System - Lightning Aspiration Tubing - STORM-PE: A Prospective, Multicenter, Randomized Controlled Trial Evaluating Anticoagulation Alone vs Anticoagulation Plus Mechanical Aspiration With the Indigo Aspiration System for the Treatment of Intermediate High Risk Acute Pulmonary Embolism
- Indigo Aspiration System - Separator 12 - Product Status
- Indigo Aspiration System - Separator 12 - Product Description
- Indigo Aspiration System - Separator 12 - STORM-PE: A Prospective, Multicenter, Randomized Controlled Trial Evaluating Anticoagulation Alone vs Anticoagulation Plus Mechanical Aspiration With the Indigo Aspiration System for the Treatment of Intermediate High Risk Acute Pulmonary Embolism
- Indigo System Aspiration Lightning 7 - Product Status
- Indigo System Aspiration Lightning 7 - Product Description
- Lightning Bolt 7 - Product Status
- Lightning Bolt 7 - Product Description
- Thunderbolt - Product Status
- Thunderbolt - Product Description
- Thunderbolt - THUNDER: Acute Ischemic Stroke Study With the Penumbra System Including Thunderbolt Aspiration Tubing
- Penumbra Inc, Key Employees
- Penumbra Inc, Key Employee Biographies
- Penumbra Inc, Subsidiaries
- Glossary
- Penumbra Inc Pipeline Products by Equipment Type
- Penumbra Inc Pipeline Products by Development Stage
- Penumbra Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AngioDynamics Inc
- Terumo Medical Corp
- Inari Medical Inc
- Stryker Corp
- Boston Scientific Corp
- Medtronic Plc
